Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.55p
   
  • Change Today:
    -0.20p
  • 52 Week High: 16.50p
  • 52 Week Low: 7.50p
  • Currency: UK Pounds
  • Shares Issued: 1,037.78m
  • Volume: 326,171
  • Market Cap: £99.11m

Latest ShareCast News

Scancell narrows loss as it progresses immunotherapy pipeline

By Josh White

Date: Thursday 11 Sep 2025

(Sharecast News) - Scancell reported progress across its immunotherapy pipeline on Thursday, as it narrowed annual losses and prepared for late-stage development of its lead melanoma treatment.

Scancell starts dosing next cohort in melanoma treatment study

By Josh White

Date: Wednesday 25 Jun 2025

(Sharecast News) - Scancell announced on Wednesday that it has started dosing patients in cohort four of its phase 2 'SCOPE' clinical trial, evaluating the intradermal administration and accelerated dosing of its iSCIB1+ immunotherapy for advanced unresectable melanoma.

Scancell shares jump on new antibody agreement with major biotech firm

By Benjamin Chiou

Date: Wednesday 12 Jun 2024

(Sharecast News) - Scancell Holdings saw shares surge on Wednesday after the the AIM-listed oncology immunotherapies group announced an agreement with a "major international biotechnology company".

Scancell appoints healthcare finance veteran as ... 29-Aug-2023 ShareCast
Scancell to present positive recent findings at ... 02-Jun-2023 ShareCast
Scancell shares jump on positive cancer vaccine ... 21-Feb-2023 ShareCast
Scancell licenses Vaccitech IP for its next vacc... 07-Nov-2022 ShareCast
Scancell enrols and doses first patient in lates... 31-Oct-2022 ShareCast
Scancell losses widen on expense of ongoing trials 28-Oct-2022 ShareCast
Scancell inks licensing deal with Nasdaq-traded ... 25-Oct-2022 ShareCast
Scancell presents new, positive data on possible... 23-Sep-2022 ShareCast
Scancell developing 'promising' new cancer treat... 23-Jun-2022 ShareCast
Scancell updates protocol for UK trial in melano... 15-Jun-2022 ShareCast
Scancell opens recruitment for cancer therapy tr... 11-Apr-2022 ShareCast
Scancell treats first patient in melanoma tumour... 19-Nov-2021 ShareCast
Scancell gets MHRA approval for Modi-1 clinical ... 26-Aug-2021 ShareCast
Scancell chooses needle-free tech for Covid vacc... 17-Aug-2021 ShareCast
Scancell makes progress with 'Covidity' trial pl... 22-Jun-2021 ShareCast
Scancell ends clinical development partnership w... 03-Feb-2021 ShareCast
Scancell selects Covid-19 vaccine candidate for ... 18-Dec-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 9.55p
Change Today -0.20p
% Change -2.05 %
52 Week High 16.50p
52 Week Low 7.50p
Volume 326,171
Shares Issued 1,037.78m
Market Cap £99.11m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 17-Oct-2025

Time Volume / Share Price
16:28 12,729 @ 9.82p
15:27 20,000 @ 9.57p
15:23 5,488 @ 9.84p
14:44 14,001 @ 9.57p
12:45 3,480 @ 9.57p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page